An AMH test estimates how many eggs remain in the ovaries, but it cannot tell whether those eggs are healthy or whether you can get pregnant. Egg count refers to the number of eggs available, while egg quality refers to their ability to develop into a healthy pregnancy. Both matter for fertility, but they are different, and age is generally a better indicator of egg quality than an AMH result.
What does an AMH test measure?
Anti-Müllerian hormone (AMH) is produced by cells surrounding developing eggs inside small, fluid-filled sacs in the ovaries called follicles. An AMH blood test measures the amount of this hormone circulating in the bloodstream.
AMH levels provide an indirect estimate of ovarian reserve, which means the supply of eggs remaining in the ovaries. Generally, higher AMH levels are associated with a larger egg supply, while lower levels are associated with a smaller supply.
According to MedlinePlus, AMH testing helps assess ovarian reserve and predict how the ovaries may respond to fertility medications. However, the test cannot assess egg health or reliably predict whether pregnancy will occur.
The distinction is important because an AMH test does not physically count every egg. It measures a hormone that reflects the activity of small developing follicles. The result is therefore an estimate rather than an exact egg count.
Egg count vs egg quality: What's the difference?
Although egg count and egg quality both contribute to reproductive health, they describe different aspects of ovarian function.
Egg count: How many eggs remain?
Egg count describes the quantity of eggs left in the ovaries. People with ovaries are born with a limited supply of eggs, and this supply gradually decreases throughout their reproductive years.
AMH testing helps estimate this remaining supply. It is particularly useful when doctors need to understand how many eggs the ovaries may produce in response to stimulation during fertility treatment.
A lower ovarian reserve does not mean that no eggs remain. It also does not establish that pregnancy is impossible.
Egg quality: How healthy are the eggs?
Egg quality describes an egg's potential to be fertilized, develop into a healthy embryo, and contribute to a successful pregnancy.
One important aspect of egg quality is whether an egg contains the correct number of chromosomes, which carry genetic information. Chromosome abnormalities become more common as reproductive age increases.
The American Society for Reproductive Medicine (ASRM) explains that age is the most useful indicator of egg quality. Age-related changes in eggs contribute to declining pregnancy rates and increasing miscarriage risk.
Someone may have a relatively high AMH level but still experience age-related changes in egg quality. Another person may have a low AMH level while still having eggs capable of producing a pregnancy.
Does a high AMH level mean good egg quality?
No. A high AMH level generally indicates a larger ovarian reserve, not healthier eggs.
For example, a person in their early 40s may have a relatively high AMH result for their age. This suggests that more developing follicles may be present, but it does not reverse the effects of age on egg quality.
Likewise, someone in their late 20s may have a lower-than-expected AMH result. That finding suggests a smaller egg supply, but it does not automatically mean their remaining eggs are of poor quality.
High AMH levels may also occur in people with polycystic ovary syndrome (PCOS), a hormonal condition that can affect ovulation. AMH alone cannot diagnose PCOS, and a high result should not automatically be interpreted as an advantage for fertility.
What do low, normal, and high AMH results mean?
AMH is commonly reported in nanograms per milliliter (ng/mL), although some laboratories use picomoles per liter (pmol/L). Interpretation depends on age, the testing method, and the laboratory's reference range.
The Cleveland Clinic describes the following broad AMH categories:
| AMH level | General interpretation |
|---|---|
| Below 1.0 ng/mL | Often considered low ovarian reserve |
| 1.0–3.0 ng/mL | Commonly described as an average range |
| Above 3.0 ng/mL | May indicate a relatively larger ovarian reserve |
These are general educational ranges, not universal diagnostic cutoffs. Laboratories may use different methods and age-based reference intervals. An AMH result should not be classified as normal or abnormal using a single cutoff without considering the clinical context.
A low result suggests fewer remaining eggs but does not measure their quality. A high result may suggest more developing follicles, but it cannot confirm that those eggs will lead to pregnancy.
How does age affect AMH and ovarian reserve?
Both egg quantity and egg quality tend to decline with age, but the two changes are not measured in the same way.
In your 20s
Ovarian reserve is generally higher during the 20s than in later reproductive years. Egg quality is also typically more favorable, although AMH levels can vary considerably among people of the same age.
A lower AMH result at this age may lead a healthcare professional to investigate ovarian reserve further, particularly when fertility treatment or other reproductive concerns are involved.
In your early 30s
AMH levels generally continue to decline as the number of remaining follicles decreases. Many people can still conceive naturally, and an AMH result alone does not determine their chances.
Age, menstrual and ovulation history, reproductive plans, and other fertility factors become important when interpreting a result.
From age 35 onward
Age-related reductions in fertility become more noticeable during the mid-to-late 30s. Both egg supply and the proportion of eggs with the correct chromosome number tend to decrease.
A normal or high AMH level does not eliminate these age-related changes. Therefore, AMH should not be used to conclude that delaying pregnancy carries no reproductive consequences.
In your 40s
Ovarian reserve is generally lower, and age-related changes in egg quality become particularly important. Even when AMH levels suggest that eggs remain, the likelihood of successful pregnancy using one's own eggs is strongly influenced by age.
These age groups describe broad reproductive patterns rather than fixed fertility deadlines.
Can AMH predict your chances of getting pregnant naturally?
AMH is not a reliable stand-alone predictor of natural pregnancy.
A low AMH result does not mean that someone cannot conceive without fertility treatment. Similarly, a normal or high result does not guarantee pregnancy.
The American College of Obstetricians and Gynecologists (ACOG) advises against using a single AMH measurement to predict time to pregnancy in women without diagnosed infertility. The evidence does not support using AMH as a general fertility test for people who have not experienced fertility problems.
Natural conception depends on several factors beyond ovarian reserve, including whether ovulation occurs, sperm health, fallopian tube function, and other reproductive conditions.
AMH also cannot reliably predict the exact age at which menopause will begin. A blood test result should not be treated as a countdown showing how many fertile years remain.
Why is AMH testing useful during IVF?
AMH testing has an established role in planning in vitro fertilization (IVF), where medications stimulate the ovaries to develop multiple eggs.
Before treatment, fertility specialists may use AMH alongside other clinical findings to estimate how strongly the ovaries are likely to respond to stimulation.
Lower AMH levels may be associated with fewer eggs retrieved, while higher levels may indicate a stronger response. This information can help clinicians choose and adjust stimulation protocols.
According to the American Society for Reproductive Medicine, AMH and antral follicle count are useful predictors of egg yield during IVF, but they are weak predictors of egg quality, pregnancy rates, and live birth rates when considered independently.
For this reason, a low AMH value should not automatically exclude someone from IVF treatment. Fertility specialists also consider age, medical history, previous treatment response, and other relevant factors.
What other tests help assess ovarian reserve?
AMH is one part of an ovarian reserve assessment. Depending on the reason for testing, a healthcare professional may recommend additional investigations.
Antral follicle count (AFC)
Antral follicle count uses an ultrasound examination to count small follicles visible in both ovaries. It provides another estimate of ovarian reserve and can help predict the response to ovarian stimulation.
AMH and AFC are often considered comparable measures of egg quantity when testing is performed and interpreted appropriately.
Follicle-stimulating hormone (FSH)
FSH is a hormone involved in stimulating ovarian follicles. It is usually measured early in the menstrual cycle when used for ovarian reserve assessment.
Higher early-cycle FSH levels may suggest reduced ovarian reserve, although FSH is less sensitive than AMH for detecting some changes in egg supply.
Estradiol
Estradiol is a form of estrogen sometimes measured alongside early-cycle FSH. It can help clinicians interpret hormone results in the context of ovarian function.
None of these tests can directly establish the quality of every remaining egg. Their main value is in estimating ovarian reserve or supporting fertility evaluation.
When should you consider getting an AMH test?
An AMH test may be appropriate when the result could help answer a specific clinical question or guide fertility treatment.
Situations in which a healthcare professional may consider ovarian reserve testing include:
- Infertility evaluation when pregnancy has not occurred as expected.
- Planning IVF or other treatments that involve ovarian stimulation.
- Assessing ovarian response before selected fertility preservation procedures.
- Evaluating ovarian function in certain medical circumstances, including after treatments that may affect the ovaries.
Testing is not routinely necessary simply to check fertility in someone without reproductive concerns. For people considering egg freezing, age and reproductive plans remain central to counseling; AMH may help estimate the expected response to stimulation but cannot predict future fertility on its own.
If pregnancy is not occurring, fertility evaluation is generally recommended after 12 months of trying for people younger than 35, or after 6 months for those aged 35 or older. People over 40, or those with known reproductive concerns, may benefit from earlier assessment.
How is the AMH blood test performed?
The AMH test involves collecting a small blood sample, usually from a vein in the arm. The procedure generally takes only a few minutes.
Unlike some reproductive hormone tests, AMH can usually be measured at any point during the menstrual cycle because its levels are relatively stable throughout the month.
Special preparation is generally unnecessary. However, hormonal contraceptives may lower measured AMH levels, so patients should tell their healthcare professional about medications they use before interpreting the result.
Laboratory methods and reference ranges can differ. Small changes between two test results do not necessarily indicate a meaningful change in fertility, particularly when different laboratories were used.
What should you do after receiving your AMH results?
The most useful next step is to interpret the result in relation to your age and the reason the test was requested.
If your AMH is low, a fertility specialist may discuss additional testing, reproductive goals, or available treatment options. A low result is not, by itself, proof of infertility.
If your AMH is high, your clinician may consider whether the result fits your age, menstrual history, ultrasound findings, and any other relevant clinical features. A higher value does not guarantee better fertility.
For people planning pregnancy, conversations about timing should consider age and the broader reproductive picture rather than relying on AMH alone.
The key takeaway: Egg quantity is not egg quality
AMH testing provides valuable information about ovarian reserve, especially when planning fertility treatment. However, it measures a marker of egg quantity rather than the health or reproductive potential of individual eggs.
Age remains a major factor in egg quality, while AMH helps estimate how the ovaries may respond to stimulation. Understanding both provides a more useful foundation for fertility discussions than interpreting either one in isolation.